Lansdale, PA, United States of America

Shannon Telesco

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Shannon Telesco in Inflammatory Bowel Disease Therapy

Introduction

Shannon Telesco is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of medical research, particularly in the area of inflammatory bowel disease. His innovative work has led to the development of a patent that aims to improve therapeutic responses for patients suffering from this condition.

Latest Patents

Shannon Telesco holds a patent titled "Methods and Compositions for Prediction of Response to a Therapy of an Inflammatory Bowel Disease." This patent represents a crucial advancement in understanding how patients can respond to various treatments, ultimately enhancing the quality of care for those affected by this challenging disease. He has 1 patent to his name.

Career Highlights

Telesco is currently employed at Janssen Biotech, Inc., where he continues to work on innovative solutions in the healthcare sector. His role at the company allows him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Throughout his career, Shannon has worked alongside notable colleagues, including Frederic Baribaud and Carrie Brodmerkel. Their combined expertise fosters a collaborative environment that drives innovation and enhances the development of new therapies.

Conclusion

Shannon Telesco's contributions to the field of inflammatory bowel disease therapy exemplify the impact of innovation in healthcare. His patent and ongoing work at Janssen Biotech, Inc. highlight the importance of research and collaboration in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…